Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026
Stocks in this Quantisnow insightHealth Care
Historical context for ADTX
Across the 5 sessions after earlier ADTX headlines, the stock closed higher 0 times and lower 5 times, with a median move of 9.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ADTX | SPY |
|---|---|---|---|
| Mar 13, 2026 | Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection | -37.0% | -0.6% |
| Mar 5, 2026 | Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026 | -8.6% | -0.6% |
| Nov 18, 2025 | Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta's Planned IPO, And Evofem's Plan to Regain a National Listing | -3.8% | -0.8% |
| Oct 30, 2025 | Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025 | -40.6% | -1.1% |
| Oct 27, 2025 | Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market | -9.8% | +1.2% |
Quantisnow market dataNASDAQ
ADTX
Aditxt Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for ADTX
Full ADTX profile on Quantisnow Follow ADTX and get a push notification the moment its next story breaks.